1. Home
  2. VCEL vs SBLK Comparison

VCEL vs SBLK Comparison

Compare VCEL & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • SBLK
  • Stock Information
  • Founded
  • VCEL 1989
  • SBLK 2006
  • Country
  • VCEL United States
  • SBLK Greece
  • Employees
  • VCEL N/A
  • SBLK N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • SBLK Marine Transportation
  • Sector
  • VCEL Health Care
  • SBLK Consumer Discretionary
  • Exchange
  • VCEL Nasdaq
  • SBLK Nasdaq
  • Market Cap
  • VCEL 2.1B
  • SBLK 2.0B
  • IPO Year
  • VCEL 1997
  • SBLK N/A
  • Fundamental
  • Price
  • VCEL $40.12
  • SBLK $18.80
  • Analyst Decision
  • VCEL Strong Buy
  • SBLK Strong Buy
  • Analyst Count
  • VCEL 8
  • SBLK 3
  • Target Price
  • VCEL $62.00
  • SBLK $22.67
  • AVG Volume (30 Days)
  • VCEL 558.9K
  • SBLK 1.5M
  • Earning Date
  • VCEL 07-31-2025
  • SBLK 08-06-2025
  • Dividend Yield
  • VCEL N/A
  • SBLK 1.06%
  • EPS Growth
  • VCEL 521.85
  • SBLK N/A
  • EPS
  • VCEL 0.05
  • SBLK 1.96
  • Revenue
  • VCEL $238,541,000.00
  • SBLK $1,236,718,000.00
  • Revenue This Year
  • VCEL $23.03
  • SBLK N/A
  • Revenue Next Year
  • VCEL $24.52
  • SBLK $14.96
  • P/E Ratio
  • VCEL $772.69
  • SBLK $9.69
  • Revenue Growth
  • VCEL 14.80
  • SBLK 25.60
  • 52 Week Low
  • VCEL $34.87
  • SBLK $12.06
  • 52 Week High
  • VCEL $63.00
  • SBLK $23.82
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 51.37
  • SBLK 62.00
  • Support Level
  • VCEL $34.87
  • SBLK $18.36
  • Resistance Level
  • VCEL $41.00
  • SBLK $19.29
  • Average True Range (ATR)
  • VCEL 1.77
  • SBLK 0.45
  • MACD
  • VCEL 0.21
  • SBLK 0.03
  • Stochastic Oscillator
  • VCEL 67.83
  • SBLK 75.74

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.

Share on Social Networks: